CClinicalTrials.gg
CompletedNCT03856385Updated Feb 27, 2019

Impact of Mindful Walking Intervention on Daily Step Count

An interventional study of Mindful Walking in Physical Inactivity, sponsored by Clemson University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-27.

Sponsored by Clemson University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled May 2017, registered Feb 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Mindful walking is a meditation practice that combines physical activity and mindfulness practice. This study examined whether a mindful walking intervention increased physical activity and improved health outcomes. The investigators conducted a randomized experiment among adults with inadequate physical activity, whereby the intervention group received a four-week, one-hour-per-week mindful walking intervention and the control group received instructions to increase physical activity (N=38). Participants in both groups received a wrist-worn step count device as participation incentive. Physical activity and health outcomes were measured with an online survey and data obtained from the wearable device at baseline (T1), post-intervention (T2), and one month after the intervention (T3).

02

Conditions studied

  • Physical Inactivity
03

In context

Lead sponsor

Clemson University is the lead sponsor of 18 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults over age 18
  • Able to read and understand English

Exclusion criteria

Exclusion Criteria:

  • Student athletes
  • Medical condition that limits slow-paced walking for 20 minutes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Mindful Walking

    Four weekly 60 minute sessions of mindful walking.

    Behavioral: Mindful Walking

  • No intervention
    Control

    Weekly email messages encouraging physical activity.

Interventions

  • BehavioralMindful Walking

    Weekly 60 minute mindful walking sessions involving observations of bodily sensations, experiences, and breath. Discussion of mindful walking experiences and encouragement to meet physical activity goals.

06

What researchers measure

Primary outcomes

  1. Rapid Assessment of Physical Activity Scale

    self-report scale of physical activity, with total score ranging from 1-10; higher scores indicate increased activity

    Time frame: one week

  2. Daily Step Counts

    Fitbit-HR device data

    Time frame: one day

  3. Screen Time

    self-report measure, 4 items assessing television and non-television time in number of hours

    Time frame: one week

Secondary outcomes

  1. Perceived Stress Scale

    self-report measure, total score ranges from 4 to 20, higher levels indicating higher levels of stress

    Time frame: one month

  2. Mental Health Inventory

    self-report measure of health-related quality of life, total score ranging from 5 to 30, with higher levels indicating higher quality of life

    Time frame: one month

  3. Brief Edinburgh Depression Scale

    self-report measure, total score ranging from 6 to 24, with higher levels indicating higher levels of depression symptoms

    Time frame: 7 days

  4. Freiburg Mindfulness Inventory

    self-report measure, total score ranging from 14 to 56 with higher scores indicating higher levels of mindfulness skills

    Time frame: 7 days

  5. Pittsburgh Sleep Quality Index

    self-report measure, total score ranging from 7 to 28, with higher scores indicating worse sleep quality

    Time frame: one month

07

Study locations

1 site
  • Clemson University
    Clemson, South Carolina 29634, United States
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared outside the research team

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03856385
Lead sponsor
Clemson University
Responsible party
Heidi Zinzow (Associate Professor, Clemson University) — Principal investigator
First posted
Feb 27, 2019
Start date
May 26, 2017
Primary completion
Aug 15, 2017
Completion
Aug 15, 2017
Last update
Feb 27, 2019

Study contacts

Lu Shi, Ph.D.
principal investigator · Clemson University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion